Scholarlink

<p>Spontaneous intracerebral hemorrhage (ICH), especially hypertensive basal ganglia hemorrhage, is a severe, often fatal stroke subtype with high morbidity and mortality. This historical review traces therapeutic progress from the 1960s to the present, emphasizing rehabilitation, peripheral–central nervous system interactions, and clinical outcomes. Molecular mechanisms, early treatments, and advances in interventions are examined. Rehabilitation strategies, such as exercise programs, stem cell therapies, and novel physical modalities, are evaluated for their effects on neuroprotection, neuroplasticity, and functional recovery. Pharmacological approaches during subacute and chronic phases are also reviewed. Clinical trials (phases I–III) are critically assessed for end points and efficacy of combined therapies. This Review highlights emerging paradigms targeting peripheral–central pathways, personalized rehabilitation, and future directions, while addressing research limitations and clinical challenges.</p><p></p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Decoding spontaneous intracerebral hemorrhage: mechanistic breakthroughs and disruptive revolution in pharmacological treatment

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年5月28日

查看全文
  • Yisheng Chen,
  • Guanghui Wu,
  • Wangzheqi Zhang,
  • Zui Zou,
  • Lei Huang,
  • Haojun Shi,
  • Qiangqiang Wang,
  • Weijian Chen,
  • Zhiwen Luo,
  • Zhijie Zhao,
  • Li Wu,
  • Zhiwei Li,
  • Jianhua Peng,
  • Yujie Chen,
  • John H. Zhang

摘要

Spontaneous intracerebral hemorrhage (ICH), especially hypertensive basal ganglia hemorrhage, is a severe, often fatal stroke subtype with high morbidity and mortality. This historical review traces therapeutic progress from the 1960s to the present, emphasizing rehabilitation, peripheral–central nervous system interactions, and clinical outcomes. Molecular mechanisms, early treatments, and advances in interventions are examined. Rehabilitation strategies, such as exercise programs, stem cell therapies, and novel physical modalities, are evaluated for their effects on neuroprotection, neuroplasticity, and functional recovery. Pharmacological approaches during subacute and chronic phases are also reviewed. Clinical trials (phases I–III) are critically assessed for end points and efficacy of combined therapies. This Review highlights emerging paradigms targeting peripheral–central pathways, personalized rehabilitation, and future directions, while addressing research limitations and clinical challenges.